PREDICTIVE AND RESPONSE BIOMARKER FOR TH-302 ANTI-CANCER THERAPY
- 专利权人:
- Threshold Pharmaceuticals; Inc.
- 发明人:
- HART, Charles,SELICK, Harold E.,SUN, Jessica
- 申请号：
- EP14783066
- 公开号：
- EP2983591A4
- 申请日:
- 2014.04.09
- 申请国别(地区):
- EP
- 年份:
- 2016
- 代理人:
- 摘要：
- Cancer patients likely to respond to HAP treatment exhibit tumor tissues with high levels of hypoxia, which can be measured using PET imaging with [18F]-HX4.
- 来源网站：
- 中国工程科技知识中心
